Spots Global Cancer Trial Database for MRI in Staging Ovarian Cancer Using MRI Contrast Agent

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: MRI in Staging Ovarian Cancer Using MRI Contrast Agent

Official Title: Værdien af MRI Til Staging af c.Ovarii-et Prospektivt Studie

Study ID: NCT00463996

Conditions

Ovarian Cancer

Interventions

Study Description

Brief Summary: Can MRI be used to stage ovarian cancer?

Detailed Description: Staging of ovarian cancer can best be performed with CT or MRI compared to ultrasound. Studies have shown an increase in pos. predictive value by adding contrast i.v. to the MR-examination protocol. We compare staging of ovarian cancer by 1.MRI without contrast (standard method) to 2.MRI with contrast agent i.v. (new method)in the same patient. Golden standard are findings at operation.